The short version.
Alcohol metabolism is NAD+-dependent. Ethanol is oxidized to acetaldehyde by alcohol dehydrogenase, and acetaldehyde is oxidized to acetate by aldehyde dehydrogenase — both reactions consume NAD+ and produce NADH. Heavy drinking shifts the NAD+/NADH ratio dramatically, and the downstream effects on gluconeogenesis, lipid handling, and oxidative stress are well-characterized.
That's the legitimate biochemical link. Whether infusing or injecting NAD+ the morning after measurably accelerates recovery beyond hydration, electrolytes, and rest is a separate question — one where the marketing has run far ahead of the evidence.
What the literature actually says.
There are no rigorous human RCTs of NAD+ for hangover recovery. The mechanism — NAD+ depletion during alcohol metabolism — is real and well-documented in biochemistry textbooks. The leap from "NAD+ gets depleted" to "exogenous NAD+ produces a meaningfully better next day" is exactly the leap that hasn't been studied.
Most of what's available is anecdotal: IV clinics report subjective improvement; users describe feeling better. Setting matters — an IV with fluids, B-complex, magnesium, and a quiet recovery room produces a real subjective effect even before the NAD+ is part of the equation. Disentangling NAD+ specifically from the rest of the protocol is exactly what controlled trials would do, and they haven't been done.
The honest framing: there's a real biochemical rationale, no controlled human evidence specifically for hangover use, and a confounder-heavy clinical experience. If you're using NAD+ for occasional recovery, treat it as a personal experiment with a plausible mechanism — not a proven therapy.
The biochemistry is real. The clinical case for IV NAD+ as a hangover therapy is mostly setting, hydration, and confidence.
Why oversight matters.
The internet sells almost any peptide as research chemicals — vials with disclaimers, no prescription, no provider, no follow-up. The risk isn't theoretical. Sterility, peptide identity, peptide content, and contamination all vary widely between gray-market vendors. The FDA has been explicit that compounded drugs aren't FDA-approved, and that research-only labels don't protect consumers when products end up in human use.
Oversight isn't a bureaucratic checkbox. It's a U.S.-licensed prescriber who reviews your history before prescribing, a 503A compounding pharmacy that sources active pharmaceutical ingredient and prepares the medication under USP 797 sterile standards, and a follow-up cadence that lets someone catch a problem before it becomes a worse one.
How Boswell handles this.
Boswell pairs you with a U.S.-licensed physician for the intake. They review your goals, medications, history, and any contraindications before prescribing. If a protocol isn't appropriate, you don't get it. If it is, the prescription goes to a 503A compounding pharmacy that prepares the medication under sterile compounding standards, labels it for you specifically, and ships it directly.
Refills aren't automatic — they involve a check-in. The point isn't to gate access; it's to keep someone clinical in the loop while you're on therapy. How Boswell works →
Questions worth asking your provider.
- How frequently is "reasonable" for occasional recovery use, and when does it become something else?
- If I'm drinking heavily enough to want this often, should we have a different conversation?
- Do I get most of the effect from fluids and electrolytes alone?
- Are there interactions with my current medications?
- What's the realistic expectation — a 20% better day or a transformed one?
Sources